Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 1, 2002, Pages 14-17

  Holt, Shawn E ^a   Brown, Elizabeth J ^a   Zipursky, Alvin ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Down syndrome; Leukemia; Megakaryoblastic leukemia; Telomerase; Transient myeloproliferative syndrome

Indexed keywords

TELOMERASE;

ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; DOWN SYNDROME; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; INFANT; LEUKEMIA; LEUKEMOGENESIS; MEGAKARYOBLAST; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BONE MARROW; CELLS, CULTURED; DOWN SYNDROME; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; TELOMERASE;

EID: 0036156452     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200201000-00005     Document Type: Article

References (18)

1. Megakaryoblastic leukemia and Down syndrome: A review
2. Myelodysplasia and acute megakaryoblastic leukemia in Down syndrome
3. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome
4. Leukemia in newborn infants with Down Syndrome
5. Specific association of human telmomerase activity with immortal cells and cancer
6. Telomeres shorten during aging of human fibroblasts
7. Telomere reduction in human colorectal carcinoma and with ageing
8. Extension of life-span by introduction of telomerase into normal human cells
9. A survey of telomerase activity in human cancer
10. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
11. Correlating telomerase activity levels with human neuroblastoma outcomes
12. Telomerase activity distinguishes between neuroblastoma with good and poor prognosis
13. Telomerase activity in acute myelogenous leukemia: Clinical and biologic implications
14. Clinical implications of telomerase activity levels in acute leukemia
15. Telomerase activity in human acute myelogenous leukemia: Inhibition of telomerase activity by differentiation-inducing agents
16. Ultrastructural studies of the megakaryoblastic leukemias of Down Syndrome
17. Inhibition of telomerase limits the growth of human cancer cells
18. A megakaryoblastic cell line from a patient with Down Syndrome-Acute Megakaryoblastic Leukemia (DS-AMKL): In vitro differentiation of megakaryoblasts